Rapid Determination of Acarbose in Tablets by 1H NMR Spectroscopy

被引:2
作者
Wang, Cong [1 ,2 ]
Zhang, Xiuli [1 ,2 ]
Yu, Mingming [1 ,2 ]
机构
[1] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao 266003, Peoples R China
[2] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao 266003, Peoples R China
关键词
Acarbose tablet; H-1; NMR; quality evaluation; assay validation; tablets; type; 2; diabetes; QUANTITATIVE NMR-SPECTROSCOPY; LIQUID-CHROMATOGRAPHY; DIABETES-MELLITUS; PERFORMANCE; VALIDATION; PRODUCTS;
D O I
10.2174/1573412915666181224125141
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Acarbose, an anti-diabetic drug, is commonly used to treat diabetes mellitus type 2. Determinationof acarbose is crucial for routine quality control of acarbose tablets. Materials and Methods: In this report, a rapid, stable and precise method was developed and validated for the quantification of acarbose in tablets by 1H NMR. Two characteristic signals at 5.80 and 2.31 ppm were used to determine acarbose. The assay was linear over a concentration range of 0.25-10.0 mg/mL. The precision was 0.26% and 1.02% for signals at 5.80 and 2.31 ppm, respectively. The average recoveries of acarbose were 99.7% and 99.2%, with RSD values 0.51% and 0.61% at two signals, respectively. Results and Discussion: The content of tested tablets was 100.4% and 100.8% of the label claim with RSD values 0.96% and 1.47% at two signals, which met the requirement of Chinese Pharmacopoeia criteria for content uniformity of tablets. The assay has been successfully applied to determine the content of acarbose in tablets for quality evaluation. Conclusion: This method has been successfully applied to determine the content of acarbose in tablets for quality evaluation.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 22 条
[1]   Quantitative 1H NMR spectroscopy [J].
Bharti, Santosh Kumar ;
Roy, Raja .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2012, 35 :5-26
[2]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[3]  
China Food and Drug Administration, 2005, CFDA GUID CHEM METH
[4]   ACARBOSE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
CLISSOLD, SP ;
EDWARDS, C .
DRUGS, 1988, 35 (03) :214-243
[5]  
Daali Y, 2002, J SEP SCI, V25, P280, DOI 10.1002/1615-9314(20020401)25:5/6<280::AID-
[6]   Quantitative NMR spectroscopy - Applications in drug analysis [J].
Holzgrabe, U ;
Deubner, R ;
Schollmayer, C ;
Waibel, B .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 38 (05) :806-812
[7]   Quantitative NMR Spectroscopy in Pharmaceutical R&D [J].
Holzgrabe, Ulrike .
EMAGRES, 2015, 4 (01) :45-56
[8]   Determination of acarbose by capillary zone electrophoresis [J].
Lachmann, B. ;
Noe, C. R. .
PHARMAZIE, 2013, 68 (07) :531-533
[9]   Method performance and validation for quantitative analysis by 1H and 31P NMR spectroscopy.: Applications to analytical standards and agricultural chemicals [J].
Maniara, G ;
Rajamoorthi, K ;
Rajan, S ;
Stockton, GW .
ANALYTICAL CHEMISTRY, 1998, 70 (23) :4921-4928
[10]   The importance of impurity analysis in pharmaceutical products: an integrated approach [J].
Rahman, N ;
Azmi, SNH ;
Wu, HF .
ACCREDITATION AND QUALITY ASSURANCE, 2006, 11 (1-2) :69-74